Search results for "migraine disorders"

showing 10 items of 106 documents

Vestibular-evoked myogenic potentials in "vestibular migraine" and Menière's disease: a sign of an electrophysiological link?

2009

Characterizations of the signs and symptoms of "vestibular migraine" and of Meniere's disease seem to overlap, suggesting that both diseases might be due to a common peripheral vestibular dysfunction. Thus, the aim of the present study was to assess vestibular-evoked myogenic potentials (VEMPs) in both disorders to determine whether there might be an electrophysiological link between the two disorders. The amplitude and latency of VEMPs were measured from the sternocleidomastoid muscle in 63 patients with vestibular migraine (median age 47 years, range 24-70 years) and in 16 patients with Meniere's disease (median age 52 years, range 36-72 years), and compared with those of 63 sex- and age-…

AdultMalemedicine.medical_specialtyVestibular evoked myogenic potentialMigraine DisordersDiseaseElectromyographyAudiologyGeneral Biochemistry Genetics and Molecular BiologyHistory and Philosophy of Scienceotorhinolaryngologic diseasesMedicineHumansMeniere DiseaseAgedmedicine.diagnostic_testbusiness.industryElectromyographyGeneral NeuroscienceCase-control studyMiddle Agedmedicine.diseasemedicine.anatomical_structureVestibuleCase-Control StudiesFemaleSacculeVestibule LabyrinthbusinessSternocleidomastoid muscleMeniere's diseaseAnnals of the New York Academy of Sciences
researchProduct

Development and validation of the Migraine Screen Questionnaire (MS-Q).

2005

Aim.—To develop and evaluate the clinimetric properties of a new migraine screening questionnaire: the Migraine Screen Questionnaire (MS-Q). Background.—Migraine is a public health problem requiring screening programs and tools to ensure early detection. Methods.—A questionnaire was developed based on the criteria of the International Headache Society (IHS) and a review of the literature by a committee of experts. Stage I: The original version of the MS-Q was distributed by mail and completed by Pfizer employees and self-administered to neurological patients; all subjects were afterward evaluated by a neurologist who was blinded to the MS-Q results, to establish an independent IHS diagnosis…

AdultMalemedicine.medical_specialtybusiness.industryNauseaMigraine DisordersValidityReproducibility of ResultsNeurological disordermedicine.diseaseLogistic regressionConfidence intervalClinical trialLogistic ModelsNeurologyMigraineCronbach's alphaSurveys and QuestionnairesPhysical therapyMedicineHumansFemaleNeurology (clinical)medicine.symptombusinessHeadache
researchProduct

Multisensorial Perception in Chronic Migraine and the Role of Medication Overuse.

2020

Multisensory processing can be assessed by measuring susceptibility to crossmodal illusions such as the Sound-Induced Flash Illusion (SIFI). When a single flash is accompanied by 2 or more beeps, it is perceived as multiple flashes (fission illusion); conversely, a fusion illusion is experienced when more flashes are matched with a single beep, leading to the perception of a single flash. Such illusory perceptions are associated to crossmodal changes in visual cortical excitability. Indeed, increasing occipital cortical excitability, by means of transcranial electrical currents, disrupts the SIFI (ie, fission illusion). Similarly, a reduced fission illusion was shown in patients with episod…

AdultMalemedicine.medical_specialtygenetic structuresmedia_common.quotation_subjectMigraine DisordersIllusionSound-induced flash illusionTriptansAudiologyAffect (psychology)03 medical and health sciencesYoung Adult0302 clinical medicineChronic Migraine030202 anesthesiologyPerceptionmedicineHeadache Disorders Secondaryaudio-visual fissionHumansPrescription Drug Overusemedia_commonCrossmodalbusiness.industryaudio-visual fusionPerspective (graphical)Middle Agedmedicine.diseaseIllusionsAnesthesiology and Pain MedicineNeurologyMigraineChronic DiseaseCortical ExcitabilityAuditory PerceptionVisual Perceptionmedication overuse headacheFemaleNeurology (clinical)chronic migrainebusiness030217 neurology & neurosurgeryPsychomotor Performancemedicine.drugThe journal of pain
researchProduct

Subgrouping factors influencing migraine intensity in women: A semi-automatic methodology based on machine learning and information geometry

2019

[EN] Background Migraine is a heterogeneous condition with multiple clinical manifestations. Machine learning algorithms permit the identification of population groups, providing analytical advantages over other modeling techniques. Objective The aim of this study was to analyze critical features that permit the differentiation of subgroups of patients with migraine according to the intensity and frequency of attacks by using machine learning algorithms. Methods Sixty-seven women with migraine participated. Clinical features of migraine, related disability (Migraine Disability Assessment Scale), anxiety/depressive levels (Hospital Anxiety and Depression Scale), anxiety state/trait levels (S…

AdultMigraine DisordersMachine learningcomputer.software_genreMachine LearningDisability Evaluation03 medical and health sciences0302 clinical medicine030202 anesthesiologyMachine learningHumansMedicine03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesInformation geometryPhysical ExaminationMigraineMultisource variabilityThesaurus (information retrieval)business.industryMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicineMigraineFISICA APLICADAFemaleArtificial intelligenceSemi automaticbusinessMATEMATICA APLICADAcomputer030217 neurology & neurosurgeryRandom forest
researchProduct

Social distancing in chronic migraine during the covid-19 outbreak: Results from a multicenter observational study

2021

Background: The restrictions taken to control the rapid spread of COVID-19 resulted in a sudden, unprecedented change in people’s lifestyle, leading to negative consequences on general health. This study aimed to estimate the impact of such changes on migraine severity during 2020 March–May lockdown. Methods: Patients affected by migraine with or without aura, diagnosed by expert physicians, completed a detailed interview comprehensive of: assessment of migraine characteristics

AdultSleep Wake Disordersmedicine.medical_specialtyAuraMigraine DisordersPhysical DistancingMetabolic equivalentArticle03 medical and health sciences0302 clinical medicineChronic MigraineQuality of lifeInternal medicineSurveys and QuestionnairesEpidemiologymedicineHumansTX341-641030212 general & internal medicineExerciseLife StyleMigraineNutritionSleep disorderSleep disorderNutrition and DieteticsCOVID-19; Migraine; Nutrition; Physical activity; Quarantine; Sleep disorder; Adult; COVID-19; Communicable Disease Control; Exercise; Feeding Behavior; Headache; Humans; Italy; Life Style; Middle Aged; Migraine Disorders; Quality of Life; Quarantine; SARS-CoV-2; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Physical Distancingbusiness.industryNutrition. Foods and food supplyPhysical activitySARS-CoV-2HeadacheCOVID-19Feeding BehaviorMiddle Agedmedicine.diseaseMigraineItalyQuarantineCommunicable Disease ControlQuality of LifeObservational studySettore MED/26 - Neurologiasense organsbusinessSleep030217 neurology & neurosurgeryFood Science
researchProduct

Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, …

2012

The objective of the study was to compare the efficacy and safety of frovatriptan and almotriptan in women with menstrually related migraine (IHS Classification of Headache disorders) enrolled in a multicenter, randomized, double-blind, cross-over study. Patients received frovatriptan 2.5 mg or almotriptan 12.5 mg in a randomized sequence: after treating 3 episodes of migraine in no more than 3 months with the first treatment, the patient was switched to the other treatment. 67 of the 96 female patients of the intention-to-treat population of the main study had regular menstrual cycles and were thus included in this subgroup analysis. 77 migraine attacks classified as related to menses were…

AdultTime FactorsOriginalMigraine DisordersPopulationAlmotriptanClinical NeurologyCarbazolesSubgroup analysisSeverity of Illness IndexAdult; Carbazoles; Cross-Over Studies; Disability Evaluation; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Proportional Hazards Models; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; TryptaminesDisability EvaluationDouble-Blind MethodAlmotriptanSeverity of illnessMedicineHumanseducationMigraine Menstrually related migraine Frovatriptan AlmotriptanMenstrually related migraineMenstruation DisturbancesMigraineMenstrually related migraineProportional Hazards Modelseducation.field_of_studyCross-Over Studiesbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseCrossover studyTryptaminesSerotonin Receptor Agonistsfrovatriptan; migraine; menstrually related migraine; almotriptanAnesthesiology and Pain MedicineTreatment OutcomeMigraineItalyAnesthesiaFemaleNeurology (clinical)businessFrovatriptanFrovatriptanmedicine.drug
researchProduct

Analysis of Safety and Tolerability Data Obtained from Over 1,500 Patients Receiving Topiramate for Migraine Prevention in Controlled Trials

2008

Objective.  Topiramate is an effective and generally well-tolerated migraine preventive therapy, as shown in three large, randomized, double-blind, placebo-controlled registration trials. Based upon efficacy/tolerability, topiramate 100 mg/day (50 mg BID) is the recommended target dose for most patients with migraine. To further assess the safety and tolerability of topiramate for migraine prevention, we analyzed safety data from 1,580 patients who participated in the three pivotal registration trials or an earlier pilot, randomized, double-blind, placebo-controlled trial. Methods.  The safety population consisted of all patients who took ≥1 dose of study medication during the double-blind …

AdultTopiramateAdolescentNauseaMigraine DisordersPopulationPhysical examinationFructosePlaceboTopiramatemedicineHumansChildAdverse effecteducationAgedRandomized Controlled Trials as Topiceducation.field_of_studymedicine.diagnostic_testbusiness.industryPatient SelectionDrug ToleranceGeneral MedicineMiddle Agedmedicine.diseaseNeuroprotective AgentsAnesthesiology and Pain MedicineTolerabilityMigraineAnesthesiaNeurology (clinical)Safetymedicine.symptombusinessmedicine.drugPain Medicine
researchProduct

Migraine and handedness.

2020

Migraine is a typically unilateral disorder in adulthood; however, the reasons for painful lateralization have been little investigated. The possible influence of manual dominance was suggested. We aimed to investigate the localization of pain in migraine attacks in right-handed and left-handed subjects. The retrospective study collected 546 patients with migraine aged between 16 and 65 years, reporting the manual dominance to the Edinburgh test. We included 466 right-handed and 80 left-handed subjects with migraine. We registered 4215 unilateral painful attacks. The right-handers had 3412 unilateral episodes; 62.8% of the attacks were characterized by pain on the right side and 37.2% by pa…

Adultmedicine.medical_specialtyNeurologyAdolescentMigraine DisordersPainDermatologyManual dominanceAudiologyLateralization of brain functionFunctional Laterality03 medical and health sciencesYoung AdultRight-handers0302 clinical medicineLeft-handersmedicineHumans030212 general & internal medicineUnilateral painHandednessMigraineNeuroradiologyAgedRetrospective Studiesbusiness.industryRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseHandPsychiatry and Mental healthManual dominanceMigraineNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgeryPsychomotor PerformanceNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE-MIG study.

2021

International audience; Background and purpose The efficacy of patent foramen ovale (PFO) closure to reduce the frequency of migraine attacks remains controversial. Methods This was a planned sub-study in migraine patients enrolled in a randomized, clinical trial designed to assess the superiority of PFO closure plus antiplatelet therapy over antiplatelet therapy alone to prevent stroke recurrence in patients younger than 60 years with a PFO-associated cryptogenic ischaemic stroke. The main outcome was the mean annual number of migraine attacks in migraine patients with aura and in those without aura, as recorded at each follow-up visit by study neurologists. Results Of 473 patients randomi…

Adultmedicine.medical_specialtyStroke patientAuraSeptal Occluder Device[SDV]Life Sciences [q-bio]Migraine DisordersForamen Ovale PatentBrain Ischemia03 medical and health sciences0302 clinical medicineInternal medicineIschaemic strokemedicineHumans030212 general & internal medicineClosure (psychology)Foramen ovale (heart)business.industryMiddle Agedmedicine.diseaseClinical trialStrokemedicine.anatomical_structureTreatment OutcomeNeurologyMigraineCardiologyPatent foramen ovaleFemaleNeurology (clinical)business030217 neurology & neurosurgeryPlatelet Aggregation InhibitorsEuropean journal of neurologyREFERENCES
researchProduct

The mysterious connection between migraine and dementia: epiphenomenon or causation? Special considerations

2022

AgingMigraine DisordersHumansmigraineSettore MED/26 - NeurologiaGeriatrics and Gerontologydementia
researchProduct